Abbott Laboratories
Abbott Laboratories Files Form 8-K
Abbott Laboratories / Key word(s): Miscellaneous Company: Abbott Laboratories TIDM: ABT Headline: Abbott Laboratories Files Form 8-K Abbott Laboratories (the “Company“) 11 May 2015 Abbott Laboratories Files Form 8-K The Company informs its shareholders that on 11 May 2015, in accordance with the U.S. Securities Exchange Act of 1934, as amended, a Current Report on Form 8-K (“Form 8-K”) was filed with the U.S. Securities and Exchange Commission (“SEC“). The Form 8-K can be found on the SEC website at http://www.sec.gov. A copy of the Form 8-K has been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.
Issued by: Abbott Laboratories CONTACT: Financial, Brian Yoor, +1-224-667-6343, or Tina Ventura, +1-224-668-7606, or Media, Melissa Brotz, +1-224-668-3456, or Scott Stoffel, +1-224-668-5201.
2015-05-12 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de |
Language: | English | |
Company: | Abbott Laboratories | |
100 Abbott Park Road | ||
60064-3500 Illinois | ||
United States | ||
Internet: | www.abbott.com | |
ISIN: | US0028241000 | |
WKN: | 850103 | |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart; Open Market in Frankfurt | |
End of News | DGAP News-Service |
356117 2015-05-12 |